subscribe
 

Biomarkers in Drug Discovery & Development

4th March 2013


2 days, 14 leading pharma experts from the industry, academia, research institutes and non-profit organisations, 12 presentations, 4 case studies, and countless networking opportunities.
 
What? When? And where?
 
Organized by Fleming Europe:
Biomarkers in Drug Discovery & Development 2012
10 – 11 September 2012
Berlin, Germany
 

At this specific event participants will meet eminent representatives from big pharma companies such as Pfizer, Sanofi, Bayer, Janssen, Novartis as well as highly qualified experts from academia and research institutes. They are enthusiastic about sharing their knowledge, experience and practices and provide further advices and fresh ideas to their business peers.
 
The discussion topics will be focused mainly on:
 
  • The latest technologies for biomarker identification
  • Methods to discover robust biomarkers for pharmacodynamic and predictive purposes
  • Contribution of imaging to decision-making in drug development
  • Successful application of biomarkers in various therapeutic areas – moving towards a personalized medicine approach
 
In order to get deeper into the discussed topics and look at the burning issues from different angles,  presentations will be complemented with real-life case studies and interactive sessions. Practical round table discussions beginning with short brainstorming sessions will allow participants to categorize the brainstorming feedback into main discussion topics, and provide the attendees the opportunity to choose a round table discussion that best fits their interest.
 
This conference is designed for:

Senior Vice Presidents, Chief Scientific Officers, Vice Presidents, Heads, Directors, Scientists, Researchers, Investigators, Professors in:
Biomarkers, Clinical Research, Drug Discovery and Development, Translational Research / Science / Imaging, Molecular Imaging, Experimental Medicine, Clinical Pharmacology, Molecular Toxicology, “Omics” Programmes, Clinical Discovery Technologies, Diagnostics, Biomarker Strategy, Assay Development, Pathway Analysis, Regulatory Affairs, etc.
 
Are you interested in exploring the best practices in accelerating the identification of drug targets, reducing the overall costs of the drug development process as well as the likelihood of adverse events? Do you want to seize the opportunity to gain strategic contacts and valuable information? Then do not hesitate and join us in Berlin.
Learn more at http://pharma.flemingeurope.com/biomarkers
 
About Fleming Europe
Established in Slovakia, Fleming Europe represents a Pan-European B2B networking channel for specialists to collect & share knowledge. Since 2004, the company has been encouraging decision makers to share their experiences through market leading conferences, trainings and webinars. The annual audience of 10,000 Banking, Defense, Energy, Oil & Gas, Pharma, Telco and Transport peers benefit from insights on industry trends when applying them to their own business practices.
For more information visit www.flemingeurope.com




Subscribe

Subscribe



Newsbrief

FREE NEWSBRIEF SUBSCRIPTION

To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited
subscribe